BAP1 and neoplasm: Recently we showed in a validation study of two cohorts that the BRCA1-associated protein 1 (BAP1) expression in tumor was a strong and independent predictor of survival in PM patients treated with first-line pemetrexed-platinum (Louw et al. 2022).